The implantable cardioverter defibrillator (ICD) represented a breakthrough in the prevention of sudden cardiac death. In addition to its use in secondary prevention, the indication of ICD therapy in primary prevention is also being intensively researched. A study published last year evaluated the relevance of ICD implantation in the acute phase of acute myocarditis and a registry study investigated the benefits of a wearable cardioverter defibrillator (WCD) for the prevention of sudden cardiac death in post-infarction patients.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal pain – chronic pancreatitis
- Acute lymphoblastic leukemia
Addition of blinatumomab to chemotherapy improves survival in children
- Advanced breast cancer
Next-generation SERD therapy with promising results
- Urticaria & urticaria-like exanthema
Case studies from pediatric dermatology
- Vitiligo in children and adolescents
Just don’t bury your head in the sand!
- Psoriasis treatment with biologics
What are the latest trends?
- Innovative care concepts: HÄPPI project
Future-oriented model for interprofessional primary care
- Moderate to severe chronic hand eczema